Filter
8845
Filtered Results: 8845
Text search:
drugs
Featured
Recommendations
727
New Publications
2183
Language
Document type
No document type
5113
Studies & Reports
1328
Guidelines
1101
Manuals
395
Strategic & Response Plan
263
Fact sheets
240
Training Material
146
Situation Updates
74
Infographics
61
Resource Platforms
49
Brochures
40
Online Courses
17
Videos
12
App
4
Dashboards/Maps
2
Countries / Regions
India
490
Global
314
Kenya
252
South Africa
200
Ethiopia
179
Nepal
172
Uganda
170
Western and Central Europe
165
Nigeria
163
Sierra Leone
154
Tanzania
133
Zambia
128
Liberia
123
Malawi
122
Latin America and the Carribbean
122
Rwanda
113
Bangladesh
111
Ghana
109
Africa
108
Ukraine
106
Myanmar / Burma
103
Eastern Europe
87
Namibia
86
Indonesia
74
Philippines
71
Russia
69
Zimbabwe
64
Congo, Democratic Republic of
62
Asia
56
Senegal
53
South–East Asia Region
51
Syria
48
Cambodia
48
Lesotho
47
Mozambique
47
Germany
47
Brazil
43
Burkina Faso
42
Botswana
39
South Sudan
38
Haiti
37
Colombia
36
Venezuela
33
West and Central Africa
31
Eswatini/ Swaziland
31
East and Southern Africa
30
Middle East and North Africa
28
Cameroon
27
Guinea
24
Tajikistan
22
Chile
22
Paraguay
22
Eastern Europe and Central Asia
20
Argentina
20
Benin
19
Peru
19
USA
17
Vietnam
17
Yemen
17
Albania
16
Afghanistan
16
Sudan
16
Moldova
15
Pakistan
15
Bolivia
14
Madagascar
14
Thailand
13
Central African Republic
13
China
12
Georgia
12
Laos
11
Armenia
11
Western Pacific Region
11
Lebanon
11
Somalia
11
North Macedonia
10
North America
9
Sri Lanka
9
Mali
9
Ecuador
9
Mexico
8
El Salvador
8
Jordan
7
United Kingdom
7
Angola
7
Palestine
6
Libya
6
Iraq
6
Serbia
5
Turkey
5
Iran
5
Burundi
5
Guinea-Bissau
5
Spain
5
Southern Africa
5
Côte d’Ivoire / Ivory Coast
5
Papua New Guinea
5
Romania
5
Chad
5
Bhutan
5
Timor Leste/ East Timor
4
Fiji
4
Estonia
4
Kyrgyzstan
4
Niger
4
Uzbekistan
4
Saudi Arabia
4
Jamaica
4
Egypt
4
Poland
4
Switzerland
3
Gambia
3
Kazakhstan
3
Morocco
3
Hungary
3
Uruguay
3
France
3
Belarus
3
Greece
3
Honduras
3
Canada
2
Singapore
2
Mongolia
2
Qatar
2
Lithuania
2
Ireland
2
Gabon
2
Turkmenistan
2
Belgium
2
Mauritius
2
Tunisia
2
Portugal
2
Nicaragua
2
Djibouti
2
Guatemala
2
North Korea
1
Australia
1
Togo
1
Congo-Brazzaville
1
Malaysia
1
Austria
1
Bulgaria
1
Italy
1
Dominican Republic
1
Japan
1
Denmark
1
Maldives
1
Norway
1
Azerbaijan
1
Latvia
1
Belize
1
Costa Rica
1
Oman
1
Panama
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
3428
Clinical Guidelines
710
Public Health
380
Women & Child Health
347
Key Resources
266
Capacity Building
144
Pharmacy & Technologies
93
Annual Report MEDBOX
2
Toolboxes
HIV
930
Mental Health
876
TB
763
COVID-19
499
NTDs
371
AMR
365
Pharmacy
269
NCDs
203
Caregiver
199
Ebola & Marburg
168
Rapid Response
154
Refugee
145
Malaria
141
Conflict
128
Disability
119
Planetary Health
119
Global Health Education
86
Health Financing Toolbox
83
Natural Hazards
57
Zika
38
Cholera
35
Polio
29
Specific Hazards
26
Social Ethics
24
South Sudan
2
Guidelines for treatment of drug-susceptible tuberculosis and patient care
2017 update
Dolutegravir HIV drug resistance (HIVDR) data from Africa remain sparse. We reviewed HIVDR results of Malawians on
dolutegravir-based antiretroviral therapy (November 2020– September 2021). Of 6462 eligible clients, 33 samples were submitted to South Africa, 27 were sequenced successfully, and 8 ...
People Who Inject Drugs
In addition, the following individuals of our external expert advisory committee made instrumental contributions to the initial design and content of the document: Billy Pick, USAID; Daniel Wolfe, Open Society Foundations; Dave Burrows, AIDS Projects Management Group; Fabi...
Ivermectin is an antiparasitic drug approved for the treatment of parasitic infections, including strongyloidiasis and onchocerciasis in humans. There is a reported increase in the use of ivermectin for the prevention and treatment of COVID-19 by the public in African Union Member States.
Currently...
Guidelines for treatment of drug-susceptible tuberculosis and patient care
Update 2017
htb supplement: 2018 Vol 19:(1)
New drugs in development
July 2018
www.i-Base.info
Multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant
tuberculosis (XDR-TB) increasingly occur in resource-constrained settings.
In the context of a national response to MDR- and XDR-TB, health workers in
TB clinics (in district hospitals and some accredited health centres) wil...
The consolidated guidelines are complemented by an operational handbook which is designed to assist with implementation of the WHO recommendations by Member States, technical partners and others who are involved in the management of patients with DR-TB. The WHO Operational Handbook on Tuberculosis, ...
In order to target resources and drugs to reach trachoma elimination targets by the year 2020, data on the burden of disease are required. Using prevalence data in African countries derived from the Global Atlas of Trachoma (GAT), the distribution of trachoma continues to be focused in East and West...
Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection
Accessed: 26.02.2020
Here you can find online courses on drug development, Pharmacology of Antibacterial Agents, pharmaceutical devices, etc.
Complete version of MDS-3 publication - Managing Drug Supply (MDS) is the leading reference on how to manage essential medicines in developing countries. MDS was originally published in 1982. It was revised in 1997 with over 10,000 copies distributed in over 60 countries worldwide. The third edition...
Tuberculosis (TB) and particularly drug-resistant TB continue to represent major public health threats in the WHO European Region. This document details the Tuberculosis action plan for the WHO European Region 2023–2030 as well as its monitoring and evaluation framework and outlines the visi...
Antibiotic resistance occurs when bacteria no longer respond to the drugs designed to kill them. Anytime antibiotics are used, they can cause antibiotic resistance.
Resistance happens when germs (bacteria and fungi) defeat the drugs designed to kill them. Any antibiotic use—in people, animals, or crops—can lead to resistance. Resistant germs are a One Health problem—they can spread between people, animals, and the environment.
In resource-limited countries, the number of available antiretroviral (ARV) drugs is relatively limited. Hence, caregivers face some caution and constraints in the changes of ARV treatment (ART) in people living with HIV (PLHIV). Our objective was to calculate the incidence, to describe the main cau...
Reporting system for the general public - This document aims to provide practical guidelines on how to set up national systems for consumers to report adverse reactions to medicines. The purpose is to help countries set up a well-organized and effective consumer reporting system within their pharmac...
Co-trimoxazole is a fixed-dose combination of two antimicrobial drugs (sulfamethoxazole and trimethoprim) that covers a variety of bacterial, fungal and protozoan infections. Co-trimoxazole preventive therapy is a feasible, well tolerated and inexpensive intervention for people living with HIV to re...
WHO’s sentinel surveys of acquired HIV resistance to dolutegravir among people receiving dolutegravir-containing antiretroviral therapy is intended for easy and frequent implementation. Results from sentinel surveys provide insight into the prevalence and year-over-year trends of dolutegravir resi...
The pamphlet "Prescription Benzodiazepines" explains the uses, effects, and risks of benzodiazepines, commonly prescribed for insomnia, anxiety, and panic attacks. It describes how these drugs enhance GABA activity to suppress brain activity, leading to short-term effects like drowsiness and anxiety...
